
ãã¡ãŠãæ°ã«COVIDã¯ã¯ãã³ã«ã€ããŠèŠåããå NIAIDè·å¡ãè·ã倱ãããšãæããŠãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
COVID-19ãã³ãããã¯ã®æäžã«ã¢ã³ãœããŒã»ãã¡ãŠãæ°ã®äžã§åããŠããå ç§å»ã»ç§åŠè ã§ææçç ç©¶è ã®ãã·ã¥ãŒã»ã¡ã¢ãªå»åž«ïŒDr. Matthew MemoliïŒã¯ãCOVID-19ã¯ã¯ãã³ã矩ååã«çåãåããåŸãè·ã倱ãå»åž«å èš±ã倱ããããããªããšå¿é ããŠããããšããæ å ±å ¬éæ³ïŒFOIAïŒè«æ±ãéããŠãšããã¯ã¿ã€ã ãºãæè¿å ¥æããé»åã¡ãŒã«ã§æããã«ãªããŸããã
2021幎ã«ã¢ã³ãœããŒã»ãã¡ãŠãå士ã®äžã§åããŠããæªæ¥çš®ã®é£éŠä¿å¥åœå±è ããCOVID-19ã¯ã¯ãã³ãšçŸ©ååã«çåãåããåŸã«è·ãšå»åž«å èš±ã倱ããããããªããšæžå¿µããŠããããšããæ°ãã«å ¬éãããã¡ãŒã«ã§æããã«ãªããŸããã
å»åž«ã§ææçç ç©¶è ã®ãã·ã¥ãŒã»ã¡ã¢ãªå士ã¯ãCOVID-19ãã³ãããã¯äžã«ææçç ç©¶æã®èšåºç ç©¶ãŠããããçããæ å ±å ¬éæ³ïŒFOIAïŒè«æ±ãéããŠãšããã¯ã»ã¿ã€ã ãºãå ¥æããã¡ãŒã«ã«ãããšãã¯ã¯ãã³ã«é¢ããæžå¿µããã¡ãŠãã«çŽæ¥äŒããŠããŸããã
ã¡ã¢ãªã¯ãã¡ãŠããžã®ã¡ãŒã«ã§æ¬¡ã®ããã«æžããŠããŸãã
ãããããã矩ååãããå€§èŠæš¡æ¥çš®ã§ç§ãã¡ããã£ãŠããããšã¯äœã®å¹æããªããå€ç°æ ªã¯ã¯ã¯ãã³ããªããŠãããã§ãã£ãããã«å ç«ãåé¿ããŠåºçŸããŸããâŠææªã®å Žåãèªç¶ãšã¯ç°ãªã圢ã§ãŠã€ã«ã¹ã®é²åãä¿ãããã³ãããã¯ãé·åŒãããããæ¬æ¥ããã眹æ£çãæ»äº¡çãé«ããããããªã©ãæå®³ãšãªãå¯èœæ§ããããŸããã
ææçç ç©¶æã¯ããã¡ãŠãã1984幎ãã2022幎ãŸã§æé·ãåããç±³åœåœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒã®äžã§éå¶ãããŠããŸãã
ã¡ã¢ãªã¯çŸåšãNIAIDã®äžäœæ©é¢ã§ããç±³åœåœç«è¡çç ç©¶æïŒNIHïŒã®çé å¯é·å®ãåããŠããŸãã
ã¡ã¢ãªã¯ãã¡ãŠãã«ã¡ãŒã«ãéã£ãã ãã§ãªããCOVID-19ã¯ã¯ãã³ãæ¿çã«å¯Ÿããçä¿ãå ¬ã«èªã£ãŠããŸããã2021幎11æã«ã¯ããŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«ã«ãç§ãã¡ã®ã¯ã¯ãã³ã®äœ¿ãæ¹ã¯ééã£ãŠãããšæããŸãããšè¿°ã¹ãŸããã
ã¡ãŒã«ã«ããã°ãã¡ã¢ãªã¯èªèº«ã®çºèšã«ãã£ãŠNIAIDã§ã®å°äœãã¯ã·ã³ãã³D.C.ã®å»åž«å èš±ã倱ãã®ã§ã¯ãªãããšæžå¿µããŠããŸããã
2021幎ãNIHã¯ã¡ã¢ãªããšããã¯ã»ã¿ã€ã ãºã®ã€ã³ã¿ãã¥ãŒã«åå ããããšã黿¢ããŸããããšããã¯ã»ã¿ã€ã ãºã®è³ªåã«å¯ŸããåœŒã®æžé¢åçã¯ãæ°ãã«å ¬éãããFOIAææžã«å«ãŸããŠããŸããã
ãã©ãŠã³ã¹ããŒã³ç ç©¶æã®ãžã§ããªãŒã»ã¿ãã«ãŒåµèšè å Œä»£è¡šã¯ãã¡ã¢ãªãCOVID-19ã®æ¥çš®ãšçŸ©ååã«å ¬ã«çåãåããããšã¯åæ°ã瀺ãããšè¿°ã¹ãŸããã
ãã¡ã¢ãªå士ã¯ãæãéèŠãªæã«åç§åŠçãªåŒ·èŠã«æµæããå倧ãªè±éã§ãããšã¿ãã«ãŒã¯è¿°ã¹ãŸããããåŒåžåšç³»ã®ãã³ãããã¯ãã¯ã¯ãã³ã ãã§ä¹ãåãããšã¯ã§ããŸãããäžå¯èœã§ããä»ã«ãå€ãã®ç§åŠè ããããç¥ã£ãŠããŸããããæ¥µããŠè³ãéãé«ãç¶æ³ã§çå®ãå£ã«ããã®ã¯ã¡ã¢ãªãšããçšæãªååšã§ãããã
ãã¯ã·ã³ãã³D.C.ã¯ç§ã®å»åž«å èš±ãçŽæ¥åãäžãããšè ããŸããã
FOIAã®ã¡ãŒã«ã«ãããšãã¡ã¢ãªã¯COVID-19ã¯ã¯ãã³ã矩ååã«çåãåããããšããããŠèªèº«ãã¯ã¯ãã³ãæ¥çš®ããªãéžæãããããšã«å¯Ÿããå ±åŸ©ãåããã®ã§ã¯ãªãããšå¿é ããŠããŸããã
NIHããã®åŸã«å·®ãæ¢ãããšããã¯ã»ã¿ã€ã ãºãžã®è³ªåãžã®åçãšããŠãã¡ã¢ãªã¯2024幎ã®ã¡ãŒã«ã§ããæžããŠããŸãã
ãç¹ã«ïŒ»ã¯ã¯ãã³ïŒœçŸ©ååã®æéã«é¢ããã¡ãŒã«ãæåã«åãåãå§ããé ã¯ãè·ã倱ãã®ã§ã¯ãªãããšå¿é ããææããããŸããâŠâŠã
ãç§ã¯èªåã®å»åž«å èš±ã®ã»ããããå¿é ããŠãããä»äºãé©åã«ç¶ããããªããªãã®ã§ã¯ãšæžå¿µããŠããŸãããã¯ã·ã³ãã³D.C.ã¯ç§ã®å»åž«å èš±ãçŽæ¥åãäžãããšè ããŠããŸãããããã¯ç§ã®ä»äºïŒå»åž«å èš±ãå¿ èŠã§ãïŒãè ããããšã«ãªãã®ã§ãç§ã¯ããŒãžãã¢å·ã®å èš±ãç³è«ãããã®ããã«ããŠèªåãå®ããŸãããã
åãäžé£ã®åçã®äžã§ãã¡ã¢ãªã¯NIHãèªèº«ã®COVID-19ã¯ã¯ãã³æ¥çš®å é€ç³è«ãæ£åŒã«æ¿èªããããšã¯äžåºŠããªãã£ããšè¿°ã¹ãŸããã
ã圌ãã¯ç§ãã¡ã1幎ãã®éãè·ãå¿é ããããŸãŸæŸçœ®ããæçµæ¿èªããäžããŸããã§ãããããã¯å°æ¥ãŸã矩ååããã£ãå Žåã«ç§ãã¡ãå®ã¶ãããã«ãããã®ã§ãããšã¡ã¢ãªã¯æžããŸããããç§ã¯ãããã¯ç§ãã¡ã«ã¯ã¯ãã³æ¥çš®ã匷èŠããããšæå³çã«è¡ããããã®ã§ãããããããŠéå«ççã§å€±æãããããããšã ãšèããŠããŸããã
ã¡ã¢ãªã¯ãã¯ã¯ãã³çŸ©ååãå«ãèªèº«ãééãã ãšæãããããã€ãã®å€±çããé¿ããã®ãå©ããããã«ããã£ãšãç©æ¥µçãã«åããããã¹ãã ã£ããšæžããŸããããããã圌ã¯è·ã®å®å®ã«ã€ããŠãäžå®ããæ±ããŠããŸããã圌ã¯ãã¯ã¯ãã³æ¥çš®ãåãå ¥ãããã匷èŠããããšæããå人ãããããšè¿°ã¹ãŸããã
2021幎12æãã¡ã¢ãªã¯ããšã·ãã¯ã¹ã»ã°ã©ã³ãã»ã©ãŠã³ãºãã§è¬æŒããè€æ°ã®NIHè·å¡ãNIHçåœå«çéšéã®é¢ä¿è ãåºåžããŸãããè¬æŒã®äžã§ã圌ã¯ã¯ã¯ãã³çŸ©ååã®å¿ èŠæ§ã«çåãåããŸããã
ã¡ãŒã«ã«ãããšãè€æ°ã®ååãã¡ã¢ãªã«è¬æã瀺ããäžæ¹ã§ã矩ååãæ¯æããçºèšãã€ãã³ãã§è¡ã£ãè ããç§çã«ã¡ã¢ãªã®ç«å Žãæ¹å€ããè ãããŸããã
2021幎ã«å€åå ããCOVID-19ã¯ã¯ãã³æ¥çš®ãäºå®äžåŒ·èŠããè² å·ãããå èªå®ãã¹ãã¹ã»ç·©åã±ã¢çè·åž«ã®ãããšã«ã»ãã€ã«ãŒã¯ãã¶ã»ãã£ãã§ã³ããŒã«æ¬¡ã®ããã«èªããŸãããããã€ãã³æä»£ã®ãå®è³ªçã«åŒ·å¶æ¥çš®ã容èªããæ¿çã¯ãæµå¯Ÿçãªè·å Žç°å¢ãåžžæ åãããŸãããã
ãè² å·è ã¯åãæšãŠãããã
2022幎ãChildrenâs Health DefenseïŒCHDïŒã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã«è² å·ãã人ã ãšã®åæ©é¢ã®ããåãã®èšé²ãæ±ããŠãç±³åœåœç«è¡çç ç©¶æïŒNIHïŒã«æ å ±å ¬éæ³ïŒFOIAïŒè«æ±ãæåºããŸããã
2023幎4æãNIHãFOIAè«æ±ã«å¿çããªãã£ããããCHDã¯èšé²ã®éç€ºãæ±ããŠNIHãæèšŽããŸããã2023幎10æã®åè§£ã§ãNIHã¯æå€§7,500ããŒãžã®ææžãé瀺ããããšã«åæããŸããã2023幎ãš2024幎ã«å ¬éããããããã®ææžã¯ã次ã®ããšã瀺ããŸããã
ãã¡ãŠãã¯ã2020幎12æã®ã¯ã¯ãã³éå§ããæ°æ¥ä»¥å
ã«ãCOVID-19ã¯ã¯ãã³ãéç¯€ãªæå®³äºè±¡ãåŒãèµ·ãããŠããããšãææ¡ããŠãããããããã®å ±åãç¡èŠããã
COVID-19ã¯ã¯ãã³æ¥çš®åŸã®è² å·ãæ»äº¡ã®å ±åâæ²»éšäžã«ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ã§è² å·ããåã©ãããã¯ã¯ãã³èªçºæ§ã®èŽæ»çå¿ççã®çäŸãå«ãâã¯ã2021幎ãš2022幎ã«ãã¡ãŠããNIHç ç©¶è
ããã®ä»ã®å
¬è¡è¡çåœå±è
ã®ããšã«å±ããŠããã
ç±³é£åå»è¬åå±ïŒFDAïŒã®ãžã£ãããã»ãŠããã³ãã¯å»åž«ããã³åœæFDAçç©è£œå€è©äŸ¡ç ç©¶ã»ã³ã¿ãŒïŒCBERïŒæé·ã®ããŒã¿ãŒã»ããŒã¯ã¹ïŒM.D., Ph.D.ïŒã¯ã2021幎åé ã«ã¯COVID-19ã¯ã¯ãã³ã®æå®³äºè±¡ãææ¡ããŠãããããå®å
šã§æå¹ããšããŠæ¥çš®ãä¿é²ãç¶ããã
FDAåœå±è
ã¯ãCOVID-19ã¯ã¯ãã³ã®æå®³äºè±¡è¢«å®³è
ãšã®äºå®ãããŠããé¢äŒããã£ãœããããããŠè¢«å®³è
ãšã®é£çµ¡ãçµ¶ã£ãã
æ©ãã2022幎1æã®æç¹ã§ãNIHç ç©¶è
ã¯COVID-19ã¯ã¯ãã³åå¿ã«é¢ããæ»èªæžã¿çäŸå ±åããã³ïŒãŸãã¯ç ç©¶è«æãå°ãªããšã850æ¬ããããšãææ¡ããŠããã
2020幎ã«ã¢ã¹ãã©ãŒãã«ã®ç±³åœã§ã®COVID-19ã¯ã¯ãã³æ²»éšäžã«è² å·ããããªã¢ã³ãã»ãã¬ãã»ã³ã¯ãCOVID-19ã¯ã¯ãã³ã§è² å·ãã人ã
ã®ããã®æ¯æŽå£äœã§ããReact19ãå
±åèšç«ããŸããããã¬ãã»ã³ã¯ãé£éŠä¿å¥åœå±ãšã®äŒåãé£çµ¡ã®äžéšã«åå ããŸããã
ãã¬ãã»ã³ã¯ããã¯ã¯ãã³è¢«å®³è ãå€ããèŠéã鳎ãããã¡ã¢ãªå»åž«ã®ãããªå»åŠç ç©¶è ãå åŽããåãããšãããŠããã®ã¯ãäœãé©ãããšã§ã¯ãªãããšè¿°ã¹ãŸããã
ãåãå ¥ããããã®ã¯ãã©ãã»ã©å€ãã®èŠåãç¡èŠãããããšããç¹ã§ãããšåœŒå¥³ã¯èšããŸãããããããã®èŠéã¯å€ç«ãããã®ã§ã¯ãªããä¿¡é Œã§ããç§åŠè ãå»åž«ãæ¿çç«æ¡è ããããŠæ¿èªã𿝿Žãå¿ æ»ã«æ±ããæ£è ããçºããããŠããŸãããã
ãã¡ã€ã¶ãŒã®COVID-19ã¯ã¯ãã³ã§è² å·ããéè·å»åž«ïŒæ¶ååšå ç§ïŒã®ããã¹ã»ããŒãå»åž«ã¯ã2020幎12æã®èªãã®ã¯ã¯ãã³è¢«å®³çŽåŸã«ãã¡ãŠããä»ã®NIHããã³NIAIDåœå±è ã«æ¯æŽãæ±ããŸãããããå®å šã«éããããããšè¿°ã¹ãŸããã
ããŒãå»åž«ã¯ããã¡ãŠããã¡ã¢ãªã®æžå¿µãç¡èŠããããšã«é©ãã¯ãªããšè¿°ã¹ãŸããã圌女ã¯èªèº«ã®æžå¿µãç¡èŠããç¶ããŠãããšããæ¬¡ã®ããã«èªããŸããã
ãç§ã¯200ããŒãžãè¶ ããåŸåŸ©æžç°¡ãæã£ãŠããŸãããå®å šã«åãåã£ãŠããããŸããã§ãããç§ã¯11ä»¶ã®VAERSã¯ã¯ãã³æå®³äºè±¡å ±åå¶åºŠïŒœå ±åãæåºããŸããããç¡èŠãããŸãããå€ãã®ä»ã®ã¯ã¯ãã³è¢«å®³è ããç§ãšãšãã«èªãã®è¢«å®³ã倧声ã§èšŽããŸãããã仿¥ã«è³ããŸã§èŠå¶åœå±ããç¡èŠãããŠããŸããç§ãã¡ã¯è»œãããããäžå·ãããŠããŸãããå€å€§ãªèäœçèŠçããã£ãã«ãããããããäœã®æ¯æŽãåŸãããŠããŸããã
ãäžè¬åžæ°ãšå»ççã¯äŸç¶ãšããŠCOVID-19ã¯ã¯ãã³ã®å®³ã«ã€ããŠç¥ããããŠããŸãããè² å·è ã¯åãæšãŠãããŸãããã
ãã¡ãŠãã¯PREPæ³ã®å 責ã·ãŒã«ãã®èåŸã«é ãã
å 補è¬R&Då¹¹éšã®ãµãŒã·ã£ã»ã©ãã£ãã¯ã¯ãããå®å šã§æå¹ããšããç©èªã«ã¯ããããŸã§äžåºŠãããšãæ£åœãªèšãèš³ã¯ãªãã£ãããšè¿°ã¹ãã¡ã¢ãªãCOVID-19ã¯ã¯ãã³è¢«å®³è ããã®èŠåããªããšãããã¡ãŠãã¯ã¯ã¯ãã³ã®å±éºæ§ãšãªã¹ã¯ãèªèããŠãããšææããã
ãããããç±³åœæ¿åºå šäœã«ãã£ãŠåœŒã«é©çšãããPREPæ³ã®å 責ã·ãŒã«ãããã以äžã圌ã¯ãããããªã¹ã¯ãå šãæ°ã«ããªãã£ãã®ã§ãããšãå ¬å ±ã®æºåãšç·æ¥äºæ æºåæ³ïŒPublic Readiness and Emergency Preparedness ActïŒãæããŠã©ãã£ãã¯ã¯è¿°ã¹ãã
PREPæ³ã¯ãå ¬è¡è¡çäžã®ç·æ¥äºæ ã®éãCOVID-19ã®æ¥çš®ãå«ã察çïŒã«ãŠã³ã¿ãŒã¡ãžã£ãŒïŒã®è£œé è ããã³å®æœè ã«å¯ŸããŠå 責ãäžããããã®æ³åŸã¯ããæ æã®äžæ£è¡çºãã®å Žåã«ã®ã¿ããã®å 責ã«å¯ŸããäŸå€ãèªããŠãããããŒãã¯ããã¡ãŠãã®è¡çºã¯ãã®éåã«åœããå¯èœæ§ããããšè¿°ã¹ãã
ããŒãã¯ããã¡ãŠãã¯ãããã§ã¯ãªããšç¥ããªãããã¯ã¯ãã³ã¯å®å šã§æå¹ã ãšå ¬ç¶ãšåãã€ããããšè¿°ã¹ãããããã¯æ æã®äžæ£è¡çºãšèŠãªãããPREPæ³ãå€§çµ±é æ©èµŠãæäŸããããããè³ å責任ããã®ä¿è·ãç¡å¹ã«ãã¹ãã§ããã
æšå¹Žã®ãã€ãã³æ¿æš©ã®æçµå±é¢ã§ããžã§ãŒã»ãã€ãã³å倧統é ã¯ã2014幎ã«é¡ã£ãŠãã¡ãŠãã®å ¬åäžã®è¡çºãã¹ãŠãäºåã«æ©èµŠããã
æ©èµŠã«ãããããããæ³ã®å°éå®¶ã¯ããã¡ãŠããäŸç¶ãšããŠå·ã¬ãã«ã®èšŽè¿œã«çŽé¢ããå¯èœæ§ããããé£éŠè°äŒã§ã®èšŒèšã«å¬åããåŸããšç€ºåããŠããã
2025幎7æãã©ã³ãã»ããŒã«äžé¢è°å¡ïŒå ±åå ã»ã±ã³ã¿ãããŒïŒã¯ãCOVID-19ã®èµ·æºã«é¢ããèªèº«ã®èª¿æ»ã®äžç°ãšããŠããã¡ãŠãã宣èªã®äžã§èšŒèšã匷å¶ããåŸããšç€ºåããã
2025幎9æãããŒã«ã¯ããã¡ãŠããååã«ãèªãã ãã¡ãã»ãŒãžãåé€ãããããæç€ºããŠããããšã瀺ã2020幎ã®è€æ°ã®ã¡ãŒã«ãå ¬éããåŸããã¡ãŠãã«è°äŒèšŒèšãèŠè«ããã2025幎11æã«ã¯ãé²è¡äžã®èª¿æ»ã®äžç°ãšããŠããã¡ãŠãã«é¢ããç±³åœæ å ±æ©é¢ã®èšé²ã®å ¬éãèŠæ±ããã